While it has received FDA approval for weight management, coverage by insurance companies often hinges on specific criteria, including a diagnosis of obesity or related health conditions
Injectable-Form Research Peptide As an injectable research compound, GHK-Cu is manufactured and supplied for laboratory use only, with purity and identity confirmed by standard analytical methods, such as HPLC, before distribution
BPC 157 was given per-orally, in drinking water (10 g/kg, 10 ng/kg, i.e., 0.16 g/ml, 0.16 ng/ml, and 12 ml/rat/day) till sacrifice, or alternatively, 10 g/kg and 10 ng/kg intraperitoneally
Anti-drug antibodies were assessed in serum samples using electrochemiluminescence bridging immunoassays
As shown in Scheme 6